Floor Willeboordse1, Jacqueline G Hugtenburg, François G Schellevis, Petra J M Elders. 1. Department of General Practice & Elderly Care Medicine, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands; NIVEL, (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Abstract
AIM: The aim of this systematic literature review is to investigate which types of patient participation in medication reviews have been practiced and what is known about the effects of patient participation within the medication review process. METHODS: A systematic literature review was performed in multiple databases using an extensive selection and quality assessment procedure. RESULTS: In total, 37 articles were included and most were assessed with a weak or moderate quality. In all studies patient participation in medication reviews was limited to the level of information giving by the patient to the professional, mainly on actual drug use. Nine studies showed limited results of effects of patient participation on the identification of drug related problems. CONCLUSIONS: The effects of patient participation are not frequently studied and poorly described in current literature. Nevertheless, involving patients can improve patients' knowledge, satisfaction and the identification of drug related problems. Patient involvement is now limited to information sharing. The profit of higher levels of patient communication and shared decision making is until now, not supported by evidence of its effectiveness.
AIM: The aim of this systematic literature review is to investigate which types of patient participation in medication reviews have been practiced and what is known about the effects of patient participation within the medication review process. METHODS: A systematic literature review was performed in multiple databases using an extensive selection and quality assessment procedure. RESULTS: In total, 37 articles were included and most were assessed with a weak or moderate quality. In all studies patient participation in medication reviews was limited to the level of information giving by the patient to the professional, mainly on actual drug use. Nine studies showed limited results of effects of patient participation on the identification of drug related problems. CONCLUSIONS: The effects of patient participation are not frequently studied and poorly described in current literature. Nevertheless, involving patients can improve patients' knowledge, satisfaction and the identification of drug related problems. Patient involvement is now limited to information sharing. The profit of higher levels of patient communication and shared decision making is until now, not supported by evidence of its effectiveness.
Authors: Vanita K Pindolia; Lesia Stebelsky; Tanya M Romain; Lori Luoma; Sandra N Nowak; Fadwa Gillanders Journal: Ann Pharmacother Date: 2009-03-31 Impact factor: 3.154
Authors: Tanya Bezreh; M Barton Laws; Tatiana Taubin; Dena E Rifkin; Ira B Wilson Journal: Patient Prefer Adherence Date: 2011-12-30 Impact factor: 2.711
Authors: Christopher J D Threapleton; James E Kimpton; Iain M Carey; Stephen DeWilde; Derek G Cook; Tess Harris; Emma H Baker Journal: Br J Clin Pharmacol Date: 2020-03-16 Impact factor: 4.335
Authors: Judith Sinnige; Joke C Korevaar; Jan van Lieshout; Gert P Westert; François G Schellevis; Jozé C Braspenning Journal: Br J Gen Pract Date: 2016-06-06 Impact factor: 5.386
Authors: Floor Willeboordse; Lucienne H Grundeken; Lisanne P van den Eijkel; François G Schellevis; Petra J M Elders; Jacqueline G Hugtenburg Journal: Int J Clin Pharm Date: 2016-02-01